DAOIB Combined With tDCS for Early-phase Dementia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 2, 2023

Study Completion Date

January 2, 2023

Conditions

Transcranial Direct Current StimulationDementia

Interventions

DRUG

DAOIB

The DAOIB dose will be adjusted every 8 weeks according to clinical evaluation.

DRUG

Placebo

placebo

DEVICE

tDCS

Trial Locations (1)

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER

NCT04737096 - DAOIB Combined With tDCS for Early-phase Dementia | Biotech Hunter | Biotech Hunter